Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

6.9%

17 terminated/withdrawn out of 245 trials

Success Rate

87.1%

+0.6% vs industry average

Late-Stage Pipeline

8%

20 trials in Phase 3/4

Results Transparency

3%

3 of 115 completed trials have results

Key Signals

48 recruiting3 with results12 terminated5 withdrawn

Enrollment Performance

Analytics

N/A
79(59.4%)
Phase 2
24(18.0%)
Phase 4
11(8.3%)
Phase 1
9(6.8%)
Phase 3
9(6.8%)
Early Phase 1
1(0.8%)
133Total
N/A(79)
Phase 2(24)
Phase 4(11)
Phase 1(9)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (245)

Showing 20 of 245 trials
NCT07273903Recruiting

Subcutaneous Immunoglobulin Therapy Effectiveness Monitoring in CIDP Patients Using Smart Devices

Role: lead

NCT06313944Recruiting

German Registry of Alzheimer's Disease Treated With Transcranial Pulse Stimulation

Role: lead

NCT07577466Not Yet Recruiting

Screening, Characterization, and Longitudinal Follow-up of Patients With Cardiac Amyloidosis

Role: lead

NCT07564700Not ApplicableNot Yet Recruiting

A Study Testing Whether Low-Dose Radiation Could Help the Immune System and Possibly Improve Early-Onset Alzheimer's Disease.

Role: lead

NCT06576934Not ApplicableRecruiting

Early TIPS in Patients With Liver Cirrhosis and Ascites

Role: collaborator

NCT07555925Not ApplicableNot Yet Recruiting

RELIEVE METAB Study

Role: lead

NCT03381794Recruiting

The German Keratoplasty Registry of the German Ophthalmological Society (DOG)

Role: collaborator

NCT07491328Recruiting

Liquid Biopsy in Paraneoplastic Neurological Syndromes

Role: lead

NCT07426991Recruiting

Cognitive Performance, Sleep Disturbances and Fatigue in Multiple Sclerosis

Role: lead

NCT07455097Active Not Recruiting

COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)

Role: lead

NCT07455422Not ApplicableNot Yet Recruiting

A Study of Barrett's Esophagus Patients: Optimization of a Risk Model to Better Predict the Development of Cancer Recurrence and the Effect of Risk Profile Disclosure on Patient Quality of Life and Fear of Cancer

Role: collaborator

NCT06523374Not ApplicableRecruiting

A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer

Role: collaborator

NCT05958706Recruiting

Mitochondrial Substrate Utilization in the Diabetic Human Heart

Role: lead

NCT07394049Not Yet Recruiting

Impact of New Hormone Replacement Therapy After Menopause on Heart Health in Women

Role: lead

NCT07365930Recruiting

NIS on the Benefits of TIPS in Patients With HCC Receiving Atezo+Bev in 1st-Line Therapy

Role: collaborator

NCT07385482Not Yet Recruiting

Chronic and Acute Cardiovascular Diseases in Elderly Intensive Care Patients

Role: lead

NCT06124586Not ApplicableRecruiting

Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)

Role: lead

NCT07372820Recruiting

METABolic Deterioration in HTX Determines Outcomes

Role: lead

NCT03539133Recruiting

Systemic Organ Communication in STEMI

Role: lead

NCT07312435Not ApplicableRecruiting

B-vitamins and Omega-3 Fatty Acids and Biomarkers of Brain Atrophy.

Role: collaborator